Data Insights

PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase II for Metastatic Castration-Resistant Prostate Cancer (mCRPC). According...

Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Data Insights

PDS-01ADC by PDS Biotechnology for Lung Cancer: Likelihood of Approval

PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase II for Lung Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Lung Cancer

Data Insights

PDS-01ADC by PDS Biotechnology for Cervical Cancer: Likelihood of Approval

PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase II for Cervical Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Cervical Cancer

Data Insights

PDS-01ADC by PDS Biotechnology for Anal Cancer: Likelihood of Approval

PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase II for Anal Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Anal Cancer

Data Insights

PDS-01ADC by PDS Biotechnology for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval

PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase II for Bile Duct Cancer (Cholangiocarcinoma). According to...

Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Bile Duct Cancer (Cholangiocarcinoma)

Data Insights

PDS-01ADC by PDS Biotechnology for Penile Cancer: Likelihood of Approval

PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase II for Penile Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Penile Cancer

Data Insights

PDS-01ADC by PDS Biotechnology for Rectal Cancer: Likelihood of Approval

PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase II for Rectal Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Rectal Cancer

Data Insights

PDS-01ADC by PDS Biotechnology for Vaginal Cancer: Likelihood of Approval

PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase II for Vaginal Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Vaginal Cancer

Data Insights

PDS-01ADC by PDS Biotechnology for Vulvar Cancer: Likelihood of Approval

PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase II for Vulvar Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Vulvar Cancer

Data Insights

PDS-01ADC by PDS Biotechnology for Esophageal Tumor: Likelihood of Approval

PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase II for Esophageal Tumor. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Esophageal Tumor

Data Insights

PDS-01ADC by PDS Biotechnology for Oropharyngeal Cancer: Likelihood of Approval

PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase II for Oropharyngeal Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Oropharyngeal Cancer

Data Insights

PDS-01ADC by PDS Biotechnology for Urinary Tract Cancer: Likelihood of Approval

PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase I for Urinary Tract Cancer. According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Urinary Tract Cancer

Data Insights

PDS-01ADC by PDS Biotechnology for Kaposi Sarcoma: Likelihood of Approval

PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase II for Kaposi Sarcoma. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Kaposi Sarcoma

Data Insights

PDS-01ADC by PDS Biotechnology for Human Papillomavirus (HPV) Associated Cancer: Likelihood of Approval

PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase II for Human Papillomavirus (HPV) Associated Cancer. According...

Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Human Papillomavirus (HPV) Associated Cancer

Data Insights

PDS-01ADC by PDS Biotechnology for Metastatic Renal Cell Carcinoma: Likelihood of Approval

PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase I for Metastatic Renal Cell Carcinoma. According to...

Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Metastatic Renal Cell Carcinoma

Data Insights

PDS-01ADC by PDS Biotechnology for Metastatic Transitional (Urothelial) Tract Cancer: Likelihood of Approval

PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase I for Metastatic Transitional (Urothelial) Tract Cancer. According...

Likelihood of Approval and Phase Transition Success Rate Model - PDS-01ADC in Metastatic Transitional (Urothelial) Tract Cancer